Immediate targets 94, 95. Invalidation 79.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels...
Looks like we have a an end to a zigzag here. Technically, we have not left FibChannel, hence the approach is risky. If the picture is right, we may see one or more impulses upwards. Wait and see.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with...
The Directional Movement Index is showing Bullish sentiment on the DMI indicator and the EMA @ 55 fib.
If the Bears crossover the EMA then close long position.
Gives you excellent entry point with minimal stop loss.
I understand the euphoria of picking on a winning horse and getting returns in excess of or even more than 100%, but what you need to pay attention to is money management and managing your positions.
You can buy stocks, you can buy futures, you can buy bonds and you can buy and/or sell options.
The key is always to use the instruments that we feel confident in and...
Novartis showin higher lows or/and a inverse head shoulder, inside a right angled broadening wedge, with a partial decline, while showing hidden bullish divergence on all three oscilators MACD, RSI and Stochastic on the Daily timeframe.
Its at the perfect spot for entry a long entry.
Target 1: 94$
Target 2: 103$
Target 3: 115$
Novartis (NVS) reported earnings last week. A Golden Cross event (considered Bullish) occurred in the stock. The chart includes a technical and fundamental analysis of Novartis.
In the NOVARTIS story , we have to scenarios :
• If the market breaks the 81,50 we can go back to 79,09 ;
• if it returns to the 84,94 then it will go up until 89,32.
NVS was among the high cap losers yesterday on the renewed coronavirus tensions and pulled back dramatically (-6.90%). This however can be the buy opportunity of the next several months as it hit the 1D MA200 (orange line) and is approaching the Higher Low trend line of the 1W Channel Up (RSI = 45.378, MACD = 1.640, ADX = 65.865).
Even though the MACD indicated...
Tilray TLRY just blow up in mid 2018 and lost from its highs around 80%. We are currently at around 70$ and Ill guess it will drop another 35% from here, to see it close the Gap at around 45$.
Tilray has only 76 Mil. shares outstanding and around 15% of it is in free float. Thats also the reason why it took off so extremely. The less shares are available the...
Pharmaceutical stocks represents a defensive asset when a positive market cycle is about to finish or when it is foreseen a cycle less positive than the previous one. In such context pharma stocks should have an advantage because of inelastic demand for such goods.
Novartis ($NVS,$NOVN) is one of the candidate to break up as the price is moving in a triangle...
Novartis has corrected about 7% towards and below its 200day moving average, and is coming back. A close above 78.35 today, would confirm that. Momentum indicators were a little oversold and are bouncing.
Stop at 77.50
Target zone: 82.80 - 84.00
